Literature DB >> 16528020

Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis.

John Arcaroli1, Eliezer Silva, James P Maloney, Qianbin He, Daiva Svetkauskaite, James R Murphy, Edward Abraham.   

Abstract

RATIONALE: The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators. There are two haplotypes for the IRAK-1 gene in Caucasians, with the variant haplotype consisting of five intron single-nucleotide polymorphisms (SNPs) and three exon SNPs.
OBJECTIVES: To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappaB and affecting outcomes from sepsis.
MEASUREMENTS AND MAIN RESULTS: One hundred fifty-five Caucasian patients with sepsis were included. Twenty-one (14%) were homozygous for the IRAK-1 variant haplotype as determined by a SNP in which T is replaced with C at nucleotide 1,595 within exon 12 of the IRAK-1 gene. The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009). There was an increased incidence of shock (p=0.047) (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1-7.7), greater requirement for more prolonged mechanical ventilator support (p=0.04) (OR, 2.7; 95% CI, 1.05-6.9), and higher 60-d mortality (p=0.05) (OR, 2.7; 95% CI, 1.0-6.8) in patients with the IRAK-1 variant haplotype compared with wild type.
CONCLUSIONS: These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappaB, more severe organ dysfunction, and higher mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528020      PMCID: PMC2662973          DOI: 10.1164/rccm.200603-341OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  58 in total

1.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Hideki Sanjo; Satoshi Uematsu; Tsuneyasu Kaisho; Katsuaki Hoshino; Osamu Takeuchi; Masaya Kobayashi; Takashi Fujita; Kiyoshi Takeda; Shizuo Akira
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

3.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

5.  Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury.

Authors:  H K Yum; J Arcaroli; J Kupfner; R Shenkar; J M Penninger; T Sasaki; K Y Yang; J S Park; E Abraham
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

6.  IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability.

Authors:  L E Jensen; A S Whitehead
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

7.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

Authors:  Eva Lorenz; Jean Paul Mira; Kathy L Frees; David A Schwartz
Journal:  Arch Intern Med       Date:  2002-05-13

8.  Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996).

Authors:  Marc Moss; David M Mannino
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

9.  The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.

Authors:  Tiffany Horng; Gregory M Barton; Richard A Flavell; Ruslan Medzhitov
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

10.  Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.

Authors:  Osamu Takeuchi; Shintaro Sato; Takao Horiuchi; Katsuaki Hoshino; Kiyoshi Takeda; Zhongyun Dong; Robert L Modlin; Shizuo Akira
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

View more
  46 in total

1.  Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

Authors:  Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

Review 2.  Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.

Authors:  Lu Gan; Liwu Li
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation.

Authors:  Lorna Ringwood; Liwu Li
Journal:  Cytokine       Date:  2008-01-30       Impact factor: 3.861

4.  Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population.

Authors:  Qi Xing Chen; Shui Jing Wu; Hai Hong Wang; Chen Lv; Bao Li Cheng; Guo Hao Xie; Xiang Ming Fang
Journal:  Hum Genet       Date:  2008-02-05       Impact factor: 4.132

Review 5.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

6.  Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice.

Authors:  Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2012-02-24       Impact factor: 4.407

7.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Authors:  Kenneth M Kaufman; Jian Zhao; Jennifer A Kelly; Travis Hughes; Adam Adler; Elena Sanchez; Joshua O Ojwang; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Mary E Comeau; Miranda C Marion; Stuart B Glenn; Rita M Cantor; Jennifer M Grossman; Bevra H Hahn; Yeong Wook Song; Chack-Yung Yu; Judith A James; Joel M Guthridge; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Juan-Manuel Anaya; Susan A Boackle; Anne M Stevens; Barry I Freedman; Lindsey A Criswell; Bernardo A Pons Estel; Joo-Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; R Hal A Scofield; Gary S Gilkeson; Joan T Merrill; Timothy B Niewold; Timothy James Vyse; Sang-Cheol Bae; Marta E Alarcón-Riquelme; Chaim O Jacob; Kathy Moser Sivils; Patrick M Gaffney; John B Harley; Amr H Sawalha; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

8.  Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia.

Authors:  Urmila Maitra; Samantha Chang; Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

Review 9.  Sepsis: links between pathogen sensing and organ damage.

Authors:  Elliott Crouser; Matthew Exline; Daren Knoell; Mark D Wewers
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Comparative genomics of Toll-like receptor signalling in five species.

Authors:  Oliver C Jann; Annemarie King; Nestor Lopez Corrales; Susan I Anderson; Kirsty Jensen; Tahar Ait-Ali; Haizhou Tang; Chunhua Wu; Noelle E Cockett; Alan L Archibald; Elizabeth J Glass
Journal:  BMC Genomics       Date:  2009-05-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.